A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT03706040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Risankizumab in Adult and Adolescent Subjects With Moderate to Severe Atopic Dermatitis
Study identification
- NCT ID
- NCT03706040
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 172 participants
Conditions and interventions
Conditions
Interventions
- Placebo Biological
- Risankizumab Biological
Biological
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 26, 2018
- Primary completion
- Oct 27, 2020
- Completion
- Apr 25, 2021
- Last update posted
- Nov 17, 2021
2018 – 2021
United States locations
- U.S. sites
- 39
- U.S. states
- 24
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Department of Dermatology /ID# 211561 | Birmingham | Alabama | 35233 | — |
| Cognitive Clinical Trials /ID# 208895 | Scottsdale | Arizona | 85258-4446 | — |
| Cosmetic Dermatology of Orange County /ID# 205801 | Anaheim | California | 92807-4780 | — |
| Center for Dermatology Clinical Research /ID# 204950 | Fremont | California | 94538 | — |
| Integrative Skin Science and Research /ID# 212486 | Sacramento | California | 95815-4500 | — |
| Cosmetic Laser Dermatology /ID# 210560 | San Diego | California | 92121-2119 | — |
| Therapeutics Clinical Research /ID# 203422 | San Diego | California | 92123 | — |
| Colorado Center for Dermatology, PLLC /ID# 216260 | Centennial | Colorado | 80111-1724 | — |
| Park Avenue Dermatology, PA /ID# 203378 | Orange Park | Florida | 32073 | — |
| MetroDerm ACC Research /ID# 205958 | Atlanta | Georgia | 30342-1418 | — |
| Skin Care Physicians of Georgia /ID# 213188 | Macon | Georgia | 31217 | — |
| University Dermatology and Vein Clinic, LLC /ID# 210702 | Darien | Illinois | 60561 | — |
| The Indiana Clinical Trials Center /ID# 211618 | Plainfield | Indiana | 46168 | — |
| Tulane University /ID# 203214 | New Orleans | Louisiana | 70112-2699 | — |
| DermAssociates /ID# 206189 | Rockville | Maryland | 20850 | — |
| Oakland Hills Dermatology /ID# 217453 | Auburn Hills | Michigan | 48326-4600 | — |
| Duplicate_Great Lakes Research, Inc. /ID# 206447 | Bay City | Michigan | 48602 | — |
| Grekin Skin Institute /ID# 210485 | Warren | Michigan | 48088 | — |
| Skin Cancer and Dermatology Institute (SCDI) /ID# 213041 | Reno | Nevada | 89052 | — |
| Psoriasis Treatment Center of Central New Jersey /ID# 203203 | East Windsor | New Jersey | 08520 | — |
| Darst Dermatology /ID# 215100 | Charlotte | North Carolina | 28277 | — |
| Dermatologists of Southwest Ohio, Inc /ID# 215104 | Mason | Ohio | 45040-4520 | — |
| Unity Clinical Research /ID# 217461 | Oklahoma City | Oklahoma | 73118 | — |
| Oregon Derm & Res. Ctr /ID# 202880 | Portland | Oregon | 97210 | — |
| Dermatologic SurgiCenter /ID# 208972 | Drexel Hill | Pennsylvania | 19026-1101 | — |
| Dermdox Dermatology Centers, PC /ID# 212259 | Hazleton | Pennsylvania | 18201 | — |
| University of Pittsburgh MC /ID# 203296 | Pittsburgh | Pennsylvania | 15260 | — |
| Derm Assoc of Plymouth Meeting /ID# 208925 | Plymouth Meeting | Pennsylvania | 19462 | — |
| RI SkinDoc /ID# 203417 | Johnston | Rhode Island | 02910-4423 | — |
| Omega Medical Research /ID# 216022 | Warwick | Rhode Island | 02886 | — |
| Health Concepts /ID# 203205 | Rapid City | South Dakota | 57702 | — |
| Rivergate Dermatology & Skin Care Center /ID# 203372 | Goodlettsville | Tennessee | 37072-2301 | — |
| Arlington Research Center, Inc /ID# 215899 | Arlington | Texas | 76011 | — |
| Tekton Research, Inc. /ID# 211558 | Austin | Texas | 78745 | — |
| Center for Clinical Studies - Houston (Binz) /ID# 203383 | Houston | Texas | 77004-8097 | — |
| Acclaim Dermatology /ID# 213026 | Sugar Land | Texas | 77479-2645 | — |
| Virginia Dermatology & Skin Cancer Center /ID# 210154 | Norfolk | Virginia | 23502-2233 | — |
| Dominion Medical Associates /ID# 212986 | Richmond | Virginia | 23219 | — |
| The Vancouver Clinic, INC. PS /ID# 202930 | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03706040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2021 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03706040 live on ClinicalTrials.gov.